Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.

Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. That said, here are three value stocks with little support and some other investments you should consider instead.

Coty (COTY)

Forward P/E Ratio: 8.4x

With a portfolio boasting many household brands, Coty (NYSE: COTY) is a beauty products powerhouse spanning cosmetics, fragrances, and skincare.

Why Do We Think COTY Will Underperform?

1. Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
2. Forecasted revenue decline of 1.2% for the upcoming 12 months implies demand will fall off a cliff
3. Revenue growth over the past three years was nullified by the company’s new share issuances as its earnings per share fell by 26.6% annually

At $2.63 per share, Coty trades at 8.4x forward P/E. If you’re considering COTY for your portfolio, see our FREE research report to learn more.

CONMED (CNMD)

Forward P/E Ratio: 10.3x

With over five decades of experience in surgical innovation since its founding in 1970, CONMED (NYSE: CNMD) develops and manufactures medical devices and equipment for surgical procedures, specializing in orthopedic and general surgery products.

Why Do We Think Twice About CNMD?

1. Weak constant currency growth over the past two years indicates challenges in maintaining its market share
2. Modest revenue base of $1.37 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
3. Estimated sales growth of 1.9% for the next 12 months implies demand will slow from its two-year trend

CONMED is trading at $45.81 per share, or 10.3x forward P/E. Dive into our free research report to see why there are better opportunities than CNMD.

OceanFirst Financial (OCFC)

Forward P/B Ratio: 0.7x

Tracing its roots back to 1902 when it began serving coastal New Jersey communities, OceanFirst Financial (NASDAQ: OCFC) operates as a regional bank holding company that provides commercial and consumer banking services primarily in New Jersey and surrounding metropolitan areas.

Why Is OCFC Risky?

1. 5.9% annual net interest income growth over the last five years was slower than its banking peers
2. Operational productivity has decreased over the last five years as its efficiency ratio worsened by 20.5 percentage points
3. Tangible book value per share tumbled by 4.5% annually over the last two years, showing banking sector trends are working against it during this cycle

OceanFirst Financial’s stock price of $17.01 implies a valuation ratio of 0.7x forward P/B. Check out our free in-depth research report to learn more about why OCFC doesn’t pass our bar.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.